(Q47791628)

5 February 2018

title

Comparative toxicity of valproic acid and its metabolites in liver slices from adult rats, weanling rats and humans (English)

1 reference

5 February 2018

author name string

R. L. Fisher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692928

18 June 2024

J. T. Sanuik

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692928

18 June 2024

H. Nau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692928

18 June 2024

A. J. Gandolfi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692928

18 June 2024

K. Brendel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20692928

18 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20692928

18 June 2024

publication date

1 June 1994

1 reference

5 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0887233394901589?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

https://api.elsevier.com/content/article/PII:0887233394901589?httpAccept=text/plain

18 June 2024

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

18 June 2024

1 reference

5 February 2018

volume

8

1 reference

5 February 2018

issue

3

1 reference

5 February 2018

page(s)

371-379

1 reference

5 February 2018

Inhibition of medium-chain fatty acid beta-oxidation in vitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Developmental toxicity of valproic acid

18 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Action of the antiepileptic drug, valproic acid, on fatty acid oxidation in isolated rat hepatocytes

18 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Current status of organ preservation with University of Wisconsin solution

18 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Valproic acid hepatic fatalities: a retrospective review

18 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

48- to 96-hour preservation of canine kidneys by initial perfusion and hypothermic storage using the Euro-Collins solution

18 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Valproate-associated hepatotoxicity and its biochemical mechanisms

18 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Valproate metabolism during hepatotoxicity associated with the drug

18 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

In- Vitro Hepatotoxicity of Three Dichlorobenzene Isomers in Human Liver Slices

18 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Toxicity of valproic acid in liver slices from sprague-dawley rats and domestic pigs

18 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Valproic Acid Hepatotoxicity in Human Liver Slices

18 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Asymmetric synthesis and enantioselective teratogenicity of 2-n-propyl-4-pentenoic acid (4-en-VPA), an active metabolite of the anticonvulsant drug, valproic acid

18 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Analysis of the factors influencing anti-epileptic drug concentrations--valproic acid

18 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies

18 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

The occurrence of intramitochondrial Ca2+ granules in valproate-induced liver injury

18 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Abnormal metabolism of valproic acid in fatal hepatic failure

18 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

A new instrument for the rapid preparation of tissue slices

18 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid

18 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Mitochondrial metabolism of valproic acid

18 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Pharmacological evaluation of various metabolites and analogues of valproic acid. Anticonvulsant and toxic potencies in mice

18 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Protein measurement with the Folin phenol reagent

18 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Twenty-four- and 48-hour canine liver preservation by simple hypothermia with prostacyclin

18 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Transfer of valproic acid and its main active unsaturated metabolite to the gestational tissue: correlation with neural tube defect formation in the mouse

18 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Valproic Acid-Induced Neural Tube Defects in Mouse and Human: Aspects of Chirality, Alternative Drug Development, Pharmacokinetics and Possible Mechanisms

18 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Valproic acid and active unsaturated metabolite (2-en): transfer to mouse liver following human therapeutic doses

18 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Hepatotoxicity to sodium valproate: a review

18 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Cytochrome P-450--catalyzed formation of delta 4-VPA, a toxic metabolite of valproic acid

18 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Fatal liver failure in children on valproate

18 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Fatal liver failure in 16 children with valproate therapy

18 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Effect of valproic acid on hepatic function

18 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Sodium valproate in the induction of unusual hepatotoxicity

18 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

Valproate-induced hepatic injury: analyses of 23 fatal cases

18 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/0887-2333(94)90158-9

18 June 2024

Identifiers

1 reference

5 February 2018

1 reference

5 February 2018